Publications by authors named "Rachel Gittelman"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

309

Total Likes

313

Extended Reach

1,428,156

Social Features

294
A
Antigen-driven expansion of public clonal T-cell populations in inflammatory bowel diseases.
Mitchell Pesesky, Ramit Bharanikumar, Lionel Le Bourhis, Hesham ElAbd, Elisa Rosati, Rachel M Gittelman

J Crohns Colitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels.
Thomas M Snyder, Rachel M Gittelman, Mark Klinger, Damon H May, Edward J Osborne

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.
Sean Nolan, Marissa Vignali, Mark Klinger, Jennifer N Dines, Ian M Kaplan, Rachel M Gittelman

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals.
Ottavia M Delmonte, Cihan Oguz, Kerry Dobbs, Katherine Myint-Hpu, Boaz Palterer, Rachel M Gittelman

J Allergy Clin Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8 T cells in persons with previous COVID-19.
Emily S Ford, Koshlan Mayer-Blackwell, Lichen Jing, Kerry J Laing, Anton M Sholukh, Rachel M Gittelman

Nat Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Sudeb C Dalai, Jennifer N Dines, Thomas M Snyder, Rachel M Gittelman, Tera Eerkes

Clin Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis.
Tilman Schneider-Hohendorf, Lisa Ann Gerdes, Béatrice Pignolet, Rachel Gittelman, Patrick Ostkamp

J Exp Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis.
Tilman Schneider-Hohendorf, Lisa Ann Gerdes, Béatrice Pignolet, Rachel Gittelman, Patrick Ostkamp

J Exp Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccination.
Emily S Ford, Koshlan Mayer-Blackwell, Lichen Jing, Anton M Sholukh, Russell St Germain, Rachel M Gittelman

Res Sq· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy.
Dalin Li, Alexander Xu, Emebet Mengesha, Rebecca Elyanow, Rachel M Gittelman

Inflamm Bowel Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity.
Rebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, Rachel M Gittelman, Jim Boonyaratanakornkit

JCI Insight· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection.
Rachel M Gittelman, Enrico Lavezzo, Thomas M Snyder, H Jabran Zahid, Cara L Carty

JCI Insight· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease.
Alexander M Xu, Dalin Li, Joseph E Ebinger, Emebet Mengesha, Rebecca Elyanow, Rachel M Gittelman

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission.
Luca Biavati, Carol Ann Huff, Anna Ferguson, Amy Sidorski, M Amanda Stevens, Rachel M Gittelman

Clin Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders.
Dalin Li, Alexander Xu, Emebet Mengesha, Rebecca Elyanow, Rachel M Gittelman

medRxiv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of HLA type, age and chronic viral infection on peripheral T-cell receptor sharing between unrelated individuals.
Sarah A Johnson, Spencer L Seale, Rachel M Gittelman, Julie A Rytlewski, Harlan S Robins

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes.
Brett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, Rachel M Gittelman, Marissa Vignali

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity.
Rebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, Rachel M Gittelman, Jim Boonyaratanakornkit

medRxiv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes.
Bart Keymeulen, André van Maurik, Dave Inman, João Oliveira, Rene McLaughlin, Rachel M Gittelman

Diabetologia· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell Transplantation.
Mark Leick, Rachel M Gittelman, Erik Yusko, Catherine Sanders, Harlan Robins

Biol Blood Marrow Transplant· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels.
Thomas M Snyder, Rachel M Gittelman, Mark Klinger, Damon H May, Edward J Osborne

medRxiv· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.
Sean Nolan, Marissa Vignali, Mark Klinger, Jennifer N Dines, Ian M Kaplan, Rachel M Gittelman

Res Sq· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive T cell repertoire characterization of non-small cell lung cancer.
Alexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, Rachel M Gittelman, Jun Li

Nat Commun· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.
Christian U Blank, Elisa A Rozeman, Lorenzo F Fanchi, Karolina Sikorska, Bart van de Wiel, Rachel M Gittelman

Nat Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis